by: Parent Project Muscular DystrophyPPMD was joined by Crystal Proud, MD for a community webinar on November 8th at 1 PM ET to discuss the recently shared Phase 3 topline results of the EMBARK study (SRP-9001-301). Siobhan Fitzgerald, Executive Director of Patient Affairs at Sarepta Therapeutics, also joined the webinar to answer frequently asked questions related to plans moving forward.
